Clinical Trials List
2004-02-01 - 2006-10-01
Phase III
Terminated4
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Jen-Jyn Lin Division of Hematology & Oncology
- Jin-Hwang Liu Division of Hematology & Oncology
- Tzeon-jye Chiou Division of Hematology & Oncology
- 林資琛 Division of Hematology & Oncology
- 王緯書 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- SUNG-HSIN KUO Division of Hematology & Oncology
- RUEY-LONG HONG Division of Hematology & Oncology
- 謝銘鈞 Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
1620 participants
